ClinicalTrials.Veeva

Menu

The Value of Myomectomy in Women With Intramural Myoma Before IVF.

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

IVF
Fibroid Uterus

Treatments

Procedure: Ovum pick up
Procedure: Embryo transfer
Drug: Human chorionic gonadotropin
Procedure: Open myomectomy
Drug: Gonadotropins

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Women with intramural myoma not reaching the endometrial cavity will be randomized to either open myomectomy or no intervention . The participants will be assessed through full history-taking with special consideration to age and the duration, type, and cause of infertility. The medical examination included general, abdominal, and vaginal examinations. Finally, an ultrasonography examination was performed to check for the presence of three or more preantral follicles and to exclude ovarian cysts. On day 3 of a natural cycle, a baseline levels of FSH, luteinizing hormone (LH),

, estradiol and anti-Müllerian hormone (AMH).Ovarian stimulation was performed using a long, antagonist, or short protocol. They were assigned to one of the 2 groups according to having an intramural myoma not indenting the cavity or not. All will be followed up by transvaginal ultrasonography . When two or more follicles had reached a mean diameter of 18 mm, oocyte maturation was triggered by intramuscular administration of hCG. Embryo transfer will be done at day 2, 3 or 5 according to the circumstances.

Full description

Women with intramural myoma not reaching the endometrial cavity will be randomized to either open myomectomy or no intervention .The participants will be assessed through full history-taking with special consideration to age and the duration, type, and cause of infertility. The medical examination included general, abdominal, and vaginal examinations. Finally, an ultrasonography examination was performed to check for the presence of three or more preantral follicles and to exclude ovarian cysts. On day 3 of a natural cycle, a baseline levels of FSH, luteinizing hormone (LH),

, estradiol and anti-Müllerian hormone (AMH).Ovarian stimulation was performed using a long, antagonist, or short protocol. They were assigned to one of the 2 groups according to having an intramural myoma not indenting the cavity or not. All will be followed up by transvaginal ultrasonography . When two or more follicles had reached a mean diameter of 18 mm, oocyte maturation was triggered by intramuscular administration of hCG. Embryo transfer will be done at day 2, 3 or 5 according to the circumstances.

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • age younger than 40 years

    • FSH) less than 10 IU/L
    • serum prolactin level normal
    • uterine cavity abnormality was excluded by hysteroscopy or hysterosalpingography

Exclusion criteria

  • abnormal endocrine function (e.g. abnormal thyroid or adrenal function)
  • ovarian cysts,
  • hydrosalpinx
  • endometrial polyps
  • male partner with azoospermia
  • ICSI performed for preimplantation genetic diagnosis.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Myomectomy group
Active Comparator group
Description:
women with intramural myoma not reaching endometrial cavity will undergo open myomectomy followed by ovarian stimulation for in vitro fertilization 6 months after the operation
Treatment:
Procedure: Open myomectomy
Drug: Gonadotropins
Procedure: Embryo transfer
Procedure: Ovum pick up
Drug: Human chorionic gonadotropin
Conservative group
Active Comparator group
Description:
women with intramural myoma not reaching endometrial cavity will undergo ovarian stimulation for in vitro fertilization
Treatment:
Drug: Gonadotropins
Procedure: Embryo transfer
Procedure: Ovum pick up
Drug: Human chorionic gonadotropin

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed Maged, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems